SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-24-005964
Filing Date
2024-11-01
Accepted
2024-11-01 20:49:53
Documents
1
Period of Report
2024-10-30

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 8689
  Complete submission text file 0001171843-24-005964.txt   10172
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Issuer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O EDESA BIOTECH INC. 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address
Nijhawan Pardeep (Reporting) CIK: 0001777962 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37619 | Film No.: 241420470